Chris Verslype
10PUBLICATIONS
60CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Mar 02, 2026
Pembrolizumab Monotherapy in Sorafenib-Treated and Treatment-Naïve Advanced Hepatocellular Carcinoma: Long-Term Follow-up of the Open-Label, Phase II KEYNOTE-224 Study.Richard S Finn, Masatoshi Kudo, Ivan Borbath
|Nov 27, 2025
Clinical Experience with Targeted Alpha-Emitter Peptide Receptor Radionuclide Therapy (α-PRRT) for Somatostatin Receptor-Positive Neuroendocrine Tumors.Hannes Leupe, Merel Cauwenbergh, Frederik Cleeren
|Dec 09, 2023
Correction: Méndez-Blanco et al. Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells. Cancers 2019, 11, 1984.Carolina Méndez-Blanco, Flavia Fondevila, Paula Fernández-Palanca
|Jan 21, 2023
Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma.Cedric Brackenier, Lisa Kinget, Sarah Cappuyns
|Nov 19, 2022
Closing spontaneous portosystemic shunts in cirrhosis: Does it make sense? Does it work? What does it take?Wim Laleman, Michael Praktiknjo, Mette Munk Lauridsen
|Jan 11, 2022
Peptide Receptor Radionuclide Therapy Targeting the Somatostatin Receptor: Basic Principles, Clinical Applications and Optimization Strategies.Niloefar Ahmadi Bidakhvidi, Karolien Goffin, Jeroen Dekervel
Pageof 2
Frequent Collaborators
3 joint publications
Wim Laleman
2 joint publications
Paula Fernández-Palanca
2 joint publications
Jeroen Dekervel
2 joint publications
José L Mauriz
2 joint publications
Jos van Pelt
2 joint publications
Christophe M Deroose
2 joint publications
Carolina Méndez-Blanco
2 joint publications
Javier González-Gallego
2 joint publications
Flavia Fondevila
2 joint publications
Geert Maleux
